These effects have won GLP-1s FDA approvals for the treatment of type 2 diabetes (T2D) and obesitywhile also making the drug class one of the most lucrative investment opportunities for biopharma companies
Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery
All of these effects are dose dependent
El programa SCALE puso de manifiesto la eficacia de LIRA 3mg en la reduccin ponderal y del permetro de cintura13, confirmndose la disminucin de HbA1c en personas con diabetes y la reduccin de la transicin de prediabetes a diabetes tras tres aos de tratamiento14 (tabla 1)
This section might seem counterintuitive in a guide about why you are gaining weight on tirzepatide , but it is important to understand that the scale is a crude tool